Nutribén® A.E.1 DIGEST

Nutribén® A.E.1 DIGEST is a first infant formula qthat due to its balanced composition and similarity to breast milk, helps reduce constipation symptoms yas it causes softer stools in babies.
This first infant formula meets the nutritional needs of babies from newborn to 6 months.

The main differentiating element of this formula is that it contains oil that is rich in palmitic acid in beta-position of the triglyceride (45%) that reduces the formation of calcium soaps, which are the main cause of constipation in babies. It also provides the following benefits:

  • Improves absorption of fats, achieving a better use of energy. 1-2
  • Improves absorption of divalent metals such as calcium and magnesium.2
  • Softer stools.3
  • Reduces the formation of calcium soaps, thus decreasing constipation.3-4
  • Improves intestinal microbiota, making it similar to the microbiota of breastfed babies.5-6
  • PHelps reduce intestinal inflammatory processes.7

Provides dietary fibre (galacto-oligosaccharides) that:8

  • Helps stimulate growth of bifidobacteria that are found in the colon.
  • Reduces constipation due to its fibre effect.
  • Strengthens the immune system.

It contains nucleotides and long-chain polyunsaturated fatty acids that improve intestinal development, reduce diarrhoea and encourage cognitive development, visual acuity and maturation of the central nervous system.9-15

– Check ingredients and product analysis.

Dosage table

This table is based on average requirements, and may only be varied if indicated by your doctor.

Levelled scoops*
Boiled water (ml.)
Feeds per day
Age: 0 to 2 weeks
2
60
8
Age: 2 to 8 weeks
3
90
7
Age: 2 to 3 months
5
150
5
Age: 3 to 6 months
6
180
5
Age: 6 months and onwards
8
240
4

*One levelled scoop is equal to approximately 4.3 g.

Categories: ,

Description

IMPORTANT: Breast milk is the best milk for your baby. This product is recommended when breastfeeding is not possible or insufficient. You should follow your competent healthcare professional’s advice.

  1. 1. Carnielli VP, Luijendijk IHT, Van Goudoever JB, Sulkers EJ, Boerlage AA, Degenhart HJ, et al. Feeding premature newborns infants palmitic acid in amounts and stereoisomeric position similar to that of human milk: effects on fat, and mineral balance. Am J Clin Nutr 1995; 61: 1037-42
  2. 2. Carnielli VP, Luijendijk IHT, Van Goudoever JB, Sulkers EJ, Boerlage AA, Degenhart HJ, et al. Structural position and amount of palmitic acid in infant formulas: effects on fat, fatty acid, and mineral balance. J Pediatr Gastroenterol Nutr 1996; 23: 553-60
  3. 3. Kennedy K, Fewtrell MS, Morley R, Abbott R, Quilan PT, Wells JCK, et al. Doubleblind, randomized trial of a synthetic triacylglycerol in formula fed-term infants:effects on stool biochemistry, stool characteristics, and bone mineralization. Am JClin Nutr 1999; 70: 920-7
  4. 4. Quilan P. Structuring fats for incorporation into infant formulas. Fat in the Diet. Proceedings of the 21 st World Congress of the International Society for Fat Research (ISF), 1995 Oct; The Hague, Netherlands. Bridwater, UK: PJ Barnes & Associates; 1996. p. 21-6
  5. 5. Yaron S, Shachar D, Abramas L, Riskin A, Bader D, Litmanovitz I, Bar-Yoseph F, Cohen T, Levi L, Lifshitz Y, Shamir R. Shaoul. Effect of high β-palmitate content in infant formula on the intestinal microbiota of term infants. J Pediatr Gastroenterol Nutr. 2013;56:376–81.
  6. 6. Yao M, Lien EL, Capeding MR, Fitzgerald M, Ramanujam K, Yuhas R, Nortington R, Lebumfacil J, Wang L, DeRusso PA. Effects of term infant formulas containing high sn-2 palmitate with and without oligofructose on stool composition, stool characteristics, and bifidogenicity: a randomized, double-blind, controlled trial. J Pediatr Gastroenterol Nutr. 2014;59:440
  7. 7. Lu P, Bar-Yoseph F, Levi L, Lifshitz Y, Witte-Bouma J, de Bruijn ACJM, Korteland-van Male AM, van Goudoever JB, Renes IB. High beta-palmitate fat controls the intestinal inflammatory response and limits intestinal damage in mucin Muc2 deficient mice. PLoS One. 2013;8:e65878
  8. 8. Supplementations of milk formula with galacto-oligosaccharides improve intestinal micro-flora and fermentation in term infant. Ben Xiao-Ming, Zhou Xiao-yu, Zhao Wei-hua, Yu Wen-liang, Pan Wei, Xhang Wei-li, Wu Sheng-mei, Christien M. Van Beusekom and Anne Schaafsma. Chinese Medical Journal, Vol 117 (6); 927-931. 2004
  9. 9. Dietary sources of nucleotides- from breast milk to weaning. Barness LA. J. Nutr.1994: 128s-130s.
  10. 10. Dietary nucleotides: cellular immune, intestinal and hepatic system effects. J. Nutr1994: 124: 144-8s
  11. 11. Modulation of the immune system by human milk and infant formula containing nucleotides. Pikering LK, Granoff DM, Erickson JR, Masor ML and cols. American Academy of Pediatrics. 1998; 101: 242-249
  12. 12. Alimentos funcionales. La importancia de los alimentos funcionales en las leches y papillas infantiles. Rivero Urgell M, Santamaría Orleáns A, Rodríguez Palmero, Seuma Mª. Nutrición Hospitalaria 2005; XX (2): 135-146
  13. 13. Nucleotide supplementation and the growth of term small for gestational age infants. Cosgrove M. (1996) Arch Dis Childh 74 (f122-f125)
  14. 14. Effects of the addition of nucleotides to an adapted milk formula on the microbial pattern of faeces in at term new born infants. Gil A. (1986) J Clin. Nutr. Gastroent.1: 127-132
  15. 15. Auestad N.; Montalbo MB.; Hall RT y Cols: Visual acuity, erythrocyte fatty acid composition and qrowth in term infants fed formulas with long chain polyunsaturated fatty acid for one year. Pediatr Res 1997; 41: 1 – 10.

Related products